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1. Introduction 
In pulmonary medicine, it is important to detect lung diseases, such as chronic obstructive 
pulmonary disease (COPD), emphysema, lung fibrosis and asthma. These diseases are 
characterized in terms of lung compliance and resistance-to-airflow. Another important 
endeavour of pulmonary medicine is mechanical ventilation of COPD patients and 
determining when to wean off these patients from the mechanical ventilator. In both these 
medical domains, lung ventilation dynamics plays a key role. 
So in this chapter, we develop the lung ventilation dynamics model in terms of monitored 
lung volume (V) and driving pressure (PL), in the form of a differential equation with 
parameters of lung compliance (C) and resistance-to-airflow (R). We obtain the solution of this 
equation in the forms of lung volume (V) function of PL, C and R. For the monitored lung 
volume V and pressure PL data, we can evaluate C and R by matching the model solution 
expression with the monitored lung volume V and driving pressure PN data. So what we have 
done here is to develop the method for determining lung compliance (C) and resistance-to-
airflow (R) as average values of C (= Ca) and R (= Ra) during the ventilation cycle. 
Now in some lung diseases such as in emphysema, the lung compliance (C) is high. In other 
lung diseases such as in asthma, the airway resistance (R) is high. So we need to determine 
the ranges of C and R for normal lung status as well as for lung disease states. Then, we can 
develop a 2-parameter R-C diagnostic coordinate plane, on which we can demarcate the 
zones for different diseases. Then, for any patient’s (R, C) value, we can plot the (R, C) point 
in the R-C diagnostic coordinate plane, and based on its location designate the lung disease 
state of the patient. A more convenient way for detecting lung disease is to combine R and C 
along with some ventilator data (such as tidal volume and breathing rate) into a non-
dimensional lung ventilator index (LVI). Then, we can determine the ranges of LVI for 
normal and disease states, and thereby employ the patient’s computed values of LVI to 
www.intechopen.com
 
Biomedical Science, Engineering and Technology 832 
designate a specific lung disease for the patient. The LVI concept for detecting lung disease 
is more convenient to adopt in clinical practice, because it enables detection of lung disease 
states in the form of just one lung-ventilation number. 
Now, in this methodology, we need to monitor (i) lung volume, by means of a spirometer, 
and (ii) lung pressure (PL) equal to Pmo (pressure at mouth) minus pleural pressure (Pp). 
The pleural pressure measurement involves placing a balloon catheter transducer through 
the nose into the esophagus, whereby the esophageal tube pressure is assumed to be 
equal to the pressure in the pleural space surrounding it. Now this procedure cannot be 
carried out non-traumatically and routinely in patients. Hence, for routineand 
noninvasive assessment of lung ventilation for detection of lung disease states, it is 
necessary to have a method for determining R and C from only lung volume data. So, 
then, we have shown how we can compute R, C and lung pressure values non-invasively 
from just lung volume measurement.  
Finally, we have presented how the lung ventilation modeling can be applied to study the 
lung ventilation dynamics of COPD patients on mechanical ventilation. We have shown 
how a COPD patient’s lung C and R can be evaluated in terms of the monitored lung 
volume and applied ventilatory pressure. We have also formulated another lung ventilator 
index to study and assess the lung status improvement of COPD patients on mechanical 
ventilation, and to decide when they can be weaned off mechanical ventilation. 
2. Lung ventilation model  
2.1 Scope 
In this section, we have developed a lung ventilation model by modeling the lung volume 
response to mouth minus pleural driving pressure (by means of a first order differential 
equation) in terms of resistance-to-airflow (R) and the lung compliance (C). The lung volume 
solution of the differential equation is matched with the clinical volume data, to evaluate the 
parameters, R and C. These parameters’ values can help us to distinguish lung disease states, 
such as obstructive lung and lung with stiffened parenchyma, asthma and emphysema. 
2.2 Role of lung ventilation 
Lung ventilation constitutes inhalation of appropriate air volume under driving pressure 
(= mouth pressure – pleuralpressure), so as to: (i) provide adequate alveolar O2 amount at 
 
 
 
  
 
Fig. 1. Lumped Lobule Lung Model. In the figure, Pa is the alveolar pressure; Pmo is the 
pressure at the mouth; Pp is the pleural pressure; Pel = Pa – Pp = 2hσ/r = 2T/r, the lung elastic 
recoil pressure; r is the radius of the alveolar chamber and h is its wall thickness; T is the 
wall tension in the alveolar chamber; V is the lung volume; R is the resistance to airflow; and 
C is the lung compliance. This figure is adopted from our work in Ref [1]. 
Air 
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appropriate partial pressure, (ii) oxygenate the pulmonary blood, and (iii) thereby provide 
adequate metabolic oxygen to the cells. Hence, ventilatory function and performance 
assessment entails determining how much air volume is provided to the alveoli, to make 
available adequate alveolar oxygen for blood oxygenation and cellular respiration. 
In this lumped lobule lung model [1], we have (i) a lumped alveolar chamber of volume V and 
pressure Pa, and (ii) lumped airway having airflow resistance R. In this airway, the pressure 
varies from Pmo at the mouth to Pa in the alveolar chamber. The pleural pressure is Pp. 
2.3 Lung ventilation analysis (using a linear first-order differential equation model) 
We first analyze Lung Ventilation function by means of a model represented by a first-order 
differential equation (Deq) in lung-volume (V) dynamics in response to the driving pressure 
PL (= mouth pressure − pleural pressure). In this model [2], the lung lobes and the alveoli are 
lumped into one lung lobule, as depicted in Figure 1. Figure 2 displays typical data of lung 
volume and flow, alveolar and pleural pressure.  
 
 
Fig. 2. Lung ventilatory model and lung-volume and pleural-pressure data. In the bottom 
figure, Curve 1 represents the negative of Pel, the pressure required to overcome lung 
elastance (=1/C) plus elastic recoil pressure at the end of expiration. Curve 2 represents 
Pp = – Pel + Pa. Now, as can be noted from Figure 1, Pa – Pp = Pel. The lung driving pressure 
PL = Pmo – Pp, and the net driving pressure PN(t) in Equation (1-b) equals PL minus Pel at end-
expiration. We define resistance-to-airflow (R) as ( ) /mo aP P V−
$ . We define lung compliance 
C = V/(Pel – Pel0) = V/(Pa – Pp) – Pel0. This figure is adopted from our work in Ref [1]. 
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Based on Figures 1 and 2, we can put:  
0
(i)          ( –  ) –  0                                                                                                           
(ii)          (2 ) /    2  /    /   at end expirati
a p el
el el
P P P
P h R T R V C Pσ
=
= = = + −( )
( )
( )
on                       
(iii)        ( –  )  /                                                                                                    
(iv)           –   –     ( –  )  
mo a
L mo p mo a a p
P P R dV dt
P P P P P P P
=
= = +
( ) 0
                                                                           
(v)           /  /   –  (lung elastic recoil pressure at end expiration) L elR dV dt V C P P
⎫⎪⎪⎪⎬⎪⎪⎪+ = − ⎭
(1-a) 
The lung ventilation model governing equation is hence formulated as: 
 
0( ) ( )L el N
V
RV P t P P t
C
+ = − =$
 (1-b) 
wherein:  
i. the values of pressurePN(t) are obtained from the PL (= Pmo – Pp ) data relative to Pel0 
ii. the parameters of this Governing Deq are lung compliance (C) and airflow-
resistance (R); in the equation both R and C are instantaneous values 
iii. V = V(t) −V0 (the lung air volume at the end-expiration = lung air volume inspired 
and expired during a single breath) 
iv. Pel0 is the lung elastic-recoil pressure at the end of expiration, and  
 0el el
V
P P
C
= −  (1-c) 
v. At end-expiration when ω t = ω T,   PL = Pel0 
Now, in order to evaluate the lung model parameters C and R, we need to simulate this 
governing equation to lung volume (V) and pressure (PN) data. This clinical data is shown in 
Figure 3. The lung volume is measured by integrating the airflow velocity-time curve, where 
the airflow velocity can be measured by means of a ventilator pneumatograph; the lung 
volume can also be measured by means of a spirometer. Inhalation and exhalation pressures 
are measured by means of a pressure transducer connected to the ventilatory tubing; 
likewise, a pressure transducer can also be similarly connected to the spirometer tubing. The 
pleural pressure is measured by placing a balloon catheter transducer through the nose into 
the esophagus; it is assumed that the esophageal tube pressure equals the pressure in the 
pleural space surrounding it. 
In Equation (1-a), we have put 
3
1
( ) sin( )N i i i
i
P t P t cω
=
= +∑ , expressed as a Fourier series. The 
governing equation (1-b) now becomes: 
 
3
1
( ) sin( )N i i i
i
V
RV P t P t c
C
ω
=
+ = = +∑$   (2-a) 
where the right-hand side represents the net driving pressure minus pleural pressure: 
PN = (Pmo – Pp) – Pel0. This PN is in fact the driving pressure (Pmo – Pp) normalized with respect 
to its value at end-expiration. Equation (2-a) can be rewritten as follows: 
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3
1
1
sin( )i i i
i
V
V P t c
RC R
ω
=
+ = +∑$  (2-b) 
wherein the P(t) clinical data (displayed in Figure 3) is represented by:  
 
3
1
( ) sin( )i i i
i
P t P t cω
=
= +∑  (3) 
 
P1= 1.581 cmH2O P2 = -5.534  cmH2O P3 = 0.5523 cmH2O 
1ω = 1.214 rad/s 2ω = 0.001414 rad/s 3ω = 2.401 rad/s 
1c = -0.3132 rad 2c = 3.297 rad 3c = -2.381 rad 
 
The pressure curve (in Figure 3) represented by the above Equation (3) closely matches the 
pressure data of Figure 3. If, in Equation (1), we designate Ra and Ca as the average values (R 
and C) for the ventilatory cycle, then the solution of Equation (2) is given by: 
 
3
2 2
1
[sin( ) cos( )]
( )
1 ( )
a a
t
R Ci a i i i a a i i
i i a a
PC t c R C t c
V t He
R C
ω ω ω
ω
−
=
+ − +
= −
+
∑  (4) 
wherein the term (RaCa) is denoted by τa. We need to have V = 0 at t = 0. Hence, putting V (at 
t = 0) = 0, gives us: 
 
3
2 2
1
[sin( ) cos( )]
1 ( )
i a i i a a i
i i a a
PC c R C c
H
R C
ω
ω
=
−
=
+
∑  (5) 
Then from Equations (4) and (5), the overall expressions for V(t) becomes 
 
3 3
2 2 2 2
1 1
[sin( ) cos( )] [sin( ) cos( )]
( )
1 1
a
t
i a i i i a i i i a i i a i
i ii a i a
PC t c t c PC c c
V t e τ
ω ω τ ω ω τ
ω τ ω τ
−
= =
+ − + −
= −
+ +
∑ ∑  (6)  
We also want that dV/dt = 0 at t =0, implying no air-flow at the start of inspiration. So then 
by differentiating Equation (6), we get the expression for air-flow (V$ ), as: 
 
23 3
2 2 2 2
1 1
[ cos( ) sin( )] [sin( ) cos( )]
1 (1 )
a
t
i a i i i i a i i i a i i a i
i ii a i a a
PC t c t c PC c c
V e τ
ω ω ω τ ω ω τ
ω τ ω τ τ
−
= =
+ + + −
= +
+ +
∑ ∑$  (7) 
For the above values of τa = 0.485 s and for ωi and cigiven by Equation (3), we get
3
1
( 0) ( / )sin( ) 0i a i
i
V t P R c
=
= = ≈∑$ , to satisfy the initial condition. 
Now by matching the above V(t) expression in Equation (6) with the V(t) data in Figure 3, and 
carrying out parameter-identification, we can determine the in vivo values of Ca, Ra and τa to be: 
 ( ) ( )1 12 20.218 L cmH O , 2.275 cmH O sL ,  0.485 sa a aC R τ− −= = =  (8) 
The computed V(t) curve, represented by Equation (6) for the above values of Ca and Ra, is 
shown in Figure 3.  
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Fig. 3. (a)The pressure curve represented by Equation (3) matched against the pressure data 
(represented by dots). (b) The volume curve represented by Equation (6), for 
Ca = 0.2132 L(cmH2O)-1 and Ra = 2.275 (cmH2O)sL-1, matched against the volume data 
represented by dots. In Figure 3(a), the terms P0, Pm and Pk refer to Equation (11). At t = tv, V 
is maximum and V$  is zero. This figure is adopted from our work in Ref [1]. 
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Let us have some validation of the average values of C and R obtained by parameter-
identification scheme, by determining the values of C and R at some specific time instants. 
For that purpose, we can put down from Equation (1-b), 
 
( )N
V
RV P t
C
+ =
$$$ $
 (9) 
Now the volume (V) curve in Figure 3(b) has an inflection point at t = ti = 1.18 s, at which
0V =$$ . At t = 1.18 s, V = 0.29 L, 0.48V =$ Ls-1, PN = 2.53 cmH2O, and 121.66 (cmH O)sNP −=$ . 
Upon substituting these values into Equation (9), we get C = 0.289 L(cmH2O)-1. Then 
substituting this value of C along with the values of V, V$ and PN into Equation (1-a), we get 
R = 3.18 (cmH2O)sL-1. These values of C and R at t = ti = 1.18 s are of the same order of 
magnitude as the average values of C and R given by Equation (8). This provides us a 
measure of confidence to our parameter-identification scheme for obtaining the average 
values Ca and Ra. 
Now since Lung disease will influence the values of R and C, these parameters can be 
employed to diagnose lung diseases. For instance in the case of emphysema, the destruction 
of lung tissue between the alveoli produces a more compliant lung, and hence results in a 
larger value of C. In asthma, there is increased airway resistance (R) due to contraction of 
the smooth muscle around the airways. In fibrosis of the lung, the membranes between the 
alveoli thicken and hence lung compliance (C) decreases. Thus by determining the normal 
and diseased ranges of the parameters R and C, we can employ this simple Lung-ventilation 
model for differential diagnosis.  
3. Non-dimensional ventilatory index  
For disease detection, it is more convenient to formulate and employ a non-dimensional 
number to serve as a ventilatory performance index LVI (to characterize ventilatory 
function), as: 
 ( )( ) ( )2 21 2 21     Ventilatory rate in s  60     60a a aLVI R C BRτ−⎡ ⎤= =⎢ ⎥⎣ ⎦  (10) 
where BR is the breathing rate.  
Now, let us obtain its order-of-magnitude by adopting representative values of Ra and Ca in 
normal and disease states. Let us take the above computed values of Ra = 2.275 (cmH2O)sL-1 
and Ca =0.2132 L(cmH2O)-1 and BR = 12 m-1 or 0.2 s-1, computed by matching Equation (6) to 
the data of Figure 3. 
Then, in a supposed normal situation, the value of LVI1 is of the order of 33.88. In the case of 
obstructive lung disease (with increased Ra), let us take Ra = 5 (cmH2O)sL-1, 
Ca = 0.12 L(cmH2O)-1 and BR = 0.3 s-1; then we get LVI1 = 118.6. For the case of emphysema 
(with enhanced Ca), let us take Ra = 2.0 (cmH2O)sL-1, Ca = 0.5 L(cmH2O)-1 and BR = 0.2 s-1; 
then we obtain LVI1 = 144. In the case of lung fibrosis (with decreased Ca), we take 
Ra = 2.0 (cmH2O)sL-1, Ca = 0.08 L(cmH2O)-1 and BR = 0.2 s-1; then we obtain LVI1 = 3.7.  
We can, hence summarize that LVI1 would be in the range of 2-5 in the case of fibrotic lung 
disease, 5-50 in normal persons, 50-150 in the case of obstructive lung disease and 150-200 
for the case of emphysema,. This would of course be needed to be verified by analyzing a 
big patient population. 
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Now, all of this analysis requires pleural pressure data, for which the patient has to be 
intubated. If now we evaluate the patient in an outpatient clinic, in which we can only monitor 
lung volume and not the pleural pressure, then let us develop a non-invasive method for 
determining lung compliance (C), resistance-to-airflow (R) and ventilatory index. 
4. For non-invasive assessment of lung status and determination of lung 
compliance and resistance-to-airflow 
Our primary need is to be able to determine lung pressure PN(t) non-invasively. If we 
observe the PN(t) curve in Figure 3(a), we can note that, during the period of time from 
t = ti = 1.18 s to t = tv = 2.02 s, we can represent it as: 
 
0sin ( )N k p iP P P t t Pω= = − +
 (11-a) 
 sin ( 1.18) 2.5k pP tω≅ − +
 
(11-b)  
where (i) Pk =Pm – P0, and Pk = 0.5 cmH2O in Figure 3(a), (ii) t = ti, the inflection point on the 
lung volume curve (= 1.18 s in Figure 3(b)), and (iii) P0 = 2.5 cmH2O. 
We can determine the value of ωp, by invoking the condition that the pressure P becomes 
maximum (= Pm) at t = tm = (tv + ti)/2. Hence, at t = tm, 
0sin ( )m k p m iP P t t Pω= − +
 
But since Pk = Pm – P0, we get 
 
0 0( )sin ( )m m p m iP P P P t tω− = − −
 
or 
sin ( ) 1p m it tω − =
 
wherein  
( ) / 2 (2.02 1.18) / 2 1.6m v it t t= + = + =  
Therefore, we have 
 
( ) (1.6 1.18) / 2 1.57p m i pt tω ω pi− = − = =
 (12) 
In Equation (12), tm = (tv + ti)/2 and both tv (= 2.02 s) and ti(= 1.18 s) can be known from the 
lung volume curve. Hence, ωp can be determined. For Figure 3 data, we get ωp = 3.73 
rad/sec.  
Hence, in our case of Figure 3 data, we can represent lung pressure PN (= P) between 
ti and tv as: 
 
0sin ( )k p iP P t t Pω= − +
 (13-a)  
 
0.5sin 3.73( 1.18) 2.5t= − +  (13-b) 
and 
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1.87 cos3.73( 1.18)P t= −$
 (13-c) 
So, in general, the parameters of the lung pressure curve are Pk and P0, since ti and ωp can be 
determined in terms of tv and ti, as per Equation (12) and Figure 3. Likewise, we can also 
represent lung volume between ti and tv as: 
 0sin ( )T v iV V t t Vω= − +  (14-a) 
whereVT is the tidal volume and V0 is the lung volume at t = ti. Based on Figure 3(b) data, 
we can rewrite Equation (14-a) as follows: 
0.25sin ( 1.18) 0.3vV tω= − +  
At t = tv = 2.02 s, V = VT = 0.55 L. Hence, (2.02 1.18) 1.57vω − = (or pi/2), so that 1.87vω = rad. 
So then Equation (14-a) can be written as: 
 
0.25sin 1.87( 1.18) 0.3V t= − +
 (14-b) 
 
0.47 cos1.87( 1.18)V t= −$
 (14-c) 
 
0.88sin 1.87( 1.18)V t= − −$$
 (14-d) 
Now based on Equation (13), we can represent the governing lung ventilation model 
Equation (1-b) as  
 0sin 3.73( 1.18)K
V
RV P t P
C
+ = − +$  (15-a) 
or as,  
 0.5sin 3.73( 1.18) 2.5
V
RV t
C
+ = − +$  (15-b) 
Let us employ this equation to determine the values of C and R at some specific points in the 
ventilation cycle. At t = ti (the inflection point) = 1.18 s, 0V =$$  Ls-2, 0.48V =$  Ls-1 and 
V = 0.3 L. Now, we can differentiate Equation (15) as: 
 ( )cos3.73( 1.18)K p
V
RV P t
C
ω+ = −
$$$  (16-a) 
or as,  
(0.5)(3.73)cos3.73( 1.18)
V
RV t
C
+ = −
$$$
 
 1.86cos3.73( 1.18)t= −  (16-b) 
Hence, from this Equation (16), we get: 
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( 0.48)
1.86
V
C
=
=
$
, or C = 0.258 L(cmH2O)-1. 
Then, upon substituting this value of C into Equation (15), we get: 
0.3
(0.48) 2.5
0.258
R + = , or R = 2.79 (cmH2O)sL-1. 
Hence at t = ti =1.18 s, C = 0.258 L(cmH2O)-1 and R = 2.79 (cmH2O)sL-1. (17) 
Let us now evaluate C and R at t = tk =1.6 s, the time associated with the peak lung pressure. 
From Equations (15) and (16), we can put down: 
 0.5sin 3.73(1.6 1.18) 2.5 3
V
RV
C
+ = − + =$  (18-a) 
 1.86 cos3.73(1.6 1.18) 0
V
RV
C
+ = − =
$$$  (18-b) 
At t = tk =1.6 s, we get from Equations (13) and (14), V = 0.48 L, 0.33V =$  Ls-1, 0.622V = −$$ Ls-2, 
P = 3 cmH2O and 0P =$  (cmH2O)s-1. 
Substituting these values into Equations (18-a) and (18-b), we get: 
 
0.48
0.33 3R
C
+ =  (19-a) 
 
0.33
0.622 0R
C
− + =  (19-b) 
from which we obtain for t = tk =1.6 s, 
 ( ) ( )1 12 2 0.22  cmH O sL ,    2.51  cmH O sLC R− −= =  (20) 
Finally, let us evaluate C and R at t = tv =2.02 s. From Equation (15), we get: 
 0.5sin 3.73(2.02 1.18) 2.5
V
RV
C
+ = − +$  (21) 
Now at t = tv =2.02 s, V = 0.55 L, 0V =$  Ls-1. So then, from Equation (21), we obtain: 
 
0.55
2.5
C
= , or C = 0.22 (cmH2O)sL-1 (22) 
It can be noted that the values of C and R given by Equations (17), (20) and (22) are similar to 
their average values Ca = 0.218 L(cmH2O)-1 and Ra = 2.275 (cmH2O)sL-1. This lends a 
measure of confidence to our Equation (15), for which V and V$  are given by Equations 
(14-b) and (14-c). 
Let us now proceed to how we can determine the values of lung pressure function 
parameters Pk and P0 along with R and C from the monitored values of lung volume. 
At t = ti =1.18 s, we have from Equation (15-a) 
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 0sin 3.73( 1.18)K
V
RV P t P
C
+ = − +$  (23) 
so that by substituting V = 0.3 L, 0.48V =$  Ls-1, we get: 
 0
0.3
(0.48)R P
C
+ =  (24) 
Also, from Equation (16), we get by substituting the values of 0.48V =$  Ls-1 and 0V =$$  Ls-2 
 
0.48
3.73 kP
C
=  (25) 
At t = tm =1.6 s, we have from Equations (15) and (16) as well as by substituting the values of 
V = 0.48 L, 0.33V =$  Ls-1 and 0.622V = −$$  Ls-2, we get: 
 0
0.48
0.33 k mR P P P
C
+ = + =  (26) 
 
0.33
0.622 0R
C
− + = , or R = 0.53/C  (27) 
Then at t = tv =2.02 s, we get from Equation (15), along with V = 0.55 L, 0V =$  Ls-1, 
 0
0.55
P
C
=  (28) 
We hence have Equations (24), (25), (26), (27) and (28) to solve and determine the best values 
of the four unknowns R, C, Pk and P0. For this purpose, we define the ranges of these four 
terms, as: 
R: 2.1, 2.2, 2.3 (cmH2O)sL-1; C: 0.20, 0.21, 0.22 L(cmH2O)-1; Pk = 0.4, 0.5, 0.6 (cmH2O); P0 = 2.4, 
2.5, 2.6 (cmH2O) 
Then, in order to satisfy these equations, we obtain for the best values of R, C, Pk and P0, 
based on the solution in Appendix, as 
 ( ) ( ) ( ) ( )112 2 2 2 2.29  cmH O sL ,   0.22 L cmH O ,   0.58  cmH O ,   2.47   cmH Ok 0R C P P−−= = = = (29) 
As can be noted, these values of C and R correspond to the average values of C and R given 
by Equation (8). This then lends credibility to our procedure for non-invasive determination 
of C and R, for lung disease detection. This procedure enables us to in fact determine lung 
pressure toward evaluation of C and R. 
Now since this procedure enables us to determine maximum lung driving pressure 
Pm = Pk + P0, we can also formulate the non-dimensional lung ventilatory index as: 
 
2
2
2 2
( )
( )(60)
( )m
R TV
LVI BR
C P
=  (30) 
wherein BR is in s-1. For our case, R = 2.275 (cmH2O)sL-1, C = 0.2132 L(cmH2O)-1, 
Pm = 3 cmH2O, and TV = 0.55 L. This gives LVI2 = 25.8. By using this LVI2 index, we can 
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expect its value to be of the order of 30 for normal subjects, 300 for COPD patients, 5 for 
emphysema patients, and 100 in the case of lung fibrosis. 
Here again, we need to determine LVI for normal lung states as well as for different lung 
disease states. We can then compare which of the formulas (10) or (30) enable better 
separation of lung disease states from the normal state. 
Comments related to values of the ranges of the parameters: Before proceeding to the next section, 
let us address the basis of providing the above indicated ranges of parameters. The lung 
ventilation volume and driving pressure curves in Figure 3 are for a normal case. By 
carrying out this procedure for other normal subjects, we can define and confirm the above 
mentioned normal ranges for these parameters, for obtaining their best values.   
Now then how do we distinguish subjects with disorders, such as obstructive lung disease 
(with increased value of Ra), emphysema (with enhanced value of Ca), lung fibrosis (with 
decreased value of Ca)?  This can be made out from the shape and values of the lung 
ventilation volume curve. So then by repeating this procedure for subjects with these 
disorders, we will be able to characterize the shapes of the lung ventilation curves for 
normal subjects and for prescribing appropriate ranges of the parameters, for obtaining the 
best values of these parameters. 
5. Lung-status evaluation and indicators for extubation of mechanically-
ventilated COPD patients 
5.1 Introduction 
In mechanically ventilated patients with chronic-obstructive-pulmonary-disease (COPD), 
elevated airway resistance and decreased lung compliance (i.e., stiffer lung) are observed 
with rapid breathing. The need for accurate predictive indicators of lung-status 
improvement is essential for ventilator discontinuation through stepwise reduction in 
mechanical support, as and when patients are increasingly able to support their own 
breathing, followed by trials of unassisted breathing preceding extubation, and ending with 
extubation. 
For this reason, we have developed an easy-to-employ lung ventilatory index (LVI), 
involving the intrinsic parameters of a lung ventilatory model, represented by a first-order 
differential equation in lung-volume response to ventilator driving pressure. The LVI is then 
employed for evaluating lung-status of chronic-obstructive-pulmonary-disease (COPD) 
patients requiring mechanical ventilation because of acute respiratory failure. 
5.2 Scope and methodology 
We recruited 13 mechanically ventilated patients with chronic obstructive pulmonary disease 
(COPD) in acute respiratory failure [3]. All patients met the diagnostic criterion of COPD. The 
first attempt of discontinuation (or weaning off the ventilator) for every patient was made 
within a short duration (not exceeding 88 hours). The patients in the study were between the 
ages of 54-83 years. All the patients were on synchronized intermittent mandatory ventilation 
(SIMV) mode with mandatory ventilation at initial intubation. Based on the physician’s 
judgment, the modes were changed for eventual discontinuation of mechanical ventilation. 
The time period for recording observations was one hour. For all purposes in this study, a 
successful ventilator discontinuation is defined as the toleration to extubation for 24 hours or 
longer and a failed ventilator discontinuation is defined as either a distress when ventilator 
support is withdrawn or the need for reintubation. Our LVI was then employed to distinguish 
patients who could be successfully weaned off the mechanical ventilator. 
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Hence, the scope of this section is that we have developed a lung-ventilatory index (LVI), 
based on a lung-model represented by a first-order differential equation in lung-volume 
dynamics to assess lung function and efficiency in the case of chronic-obstructive-pulmonary-
disease (COPD) patients requiring mechanical ventilation because of acute respiratory failure. 
Herein, we have attempted to evaluate the efficacy of the LVI in identifying improving or 
deteriorating lung condition in such mechanically ventilated chronic-obstructive-pulmonary-
disease (COPD) patients, and consequently if LVI can be used as a potential indicator to 
predict ventilator discontinuation. In our bioengineering study of 13 COPD patients who were 
mechanically ventilated because of acute respiratory failure, when their LVI was evaluated, it 
provided clear separation between patients with improving and deteriorating lung condition. 
Finally, we formulated a lung improvement index (LII) representative of the overall lung 
response to treatment and medication, and a parameter m that corresponds to the rate of lung 
improvement and reflects the stability of lung-status with time. This chapter is based on our 
previous chapter [3] in the book on Human Respiration (edited by V. Kulish and published by 
WIT Press) and other works on this subject [4-9]. 
5.3 Lung ventilation model 
From a ventilatory mechanics viewpoint, the lungs can be considered analogous to a 
balloon, which can be inflated and deflated (passively).  The gradient between the mouth-
pressure (Pmo) and the alveolar pressure (Pal) causes respiration to occur. During inspiration, 
Pm > Pal, which causes air to enter the lungs. During expiration Pal increases, and is greater 
than Pmo; this causes the air to be expelled out of the lungs passively. These pressure 
differentials provide a force driving the gas flow. The pressure difference between the 
alveolar pressure (Pal) and pleural pressure (Pp) counter balances the elastic recoil. Thus the 
assessment of respiratory mechanics involves the measurement of flows, volumes (flow 
integrated over time) and pressure-gradients. The lung ventilation model (shown in 
Figure 1) is based on the same dynamic-equilibrium differential equation (Equation 1-b), 
expressing lung volume response to pressure across the lung, as: 
 0( ) sin( )L el
V
RV P t P B t
C
ω+ = − =$  (31) 
wherein:  
i. the total positive pressure across the lungs, PL = Pmo – Pp, wherein Pp is determined 
by intubating the patient, and assuming that the pressure in the relaxed esophageal 
tube equals the pressure in the pleural space surrounding it. 
ii. the parameters of the governing Equation (31) are lung compliance (C) and airflow-
resistance (R), with both R and C being instantaneous values 
iii. V = V(t) – Ve (wherein Ve is the end-expiratory lung volume) 
iv. Pel0 is the end-expiratory pressure   
v. the net driving pressure PN = PL - Pel0 
Let B be the amplitude of the net pressure wave form applied by the ventilator, Ca be the 
averaged dynamic lung compliance, Ra the averaged dynamic resistance to airflow, the 
driving pressure PL be given as PL = Pel0 + Bsin(ωt), and the net pressure PN be given by 
PN = Bsin(ωt), as depicted in Figure 4. The governing equation (31) then becomes:  
 sin( )a N
a
V
R V P B t
C
ω+ = =$  (32) 
www.intechopen.com
 
Biomedical Science, Engineering and Technology 844 
 
 
 
 
 
Fig. 4. Lung ventilatory model data shows air-flow (V$ ) and volume (V) and net pressure 
(PN). Pause pressure (P0) occurs at tv, at which the volume is maximum (TV = tidal volume). 
Δt is the phase difference between the time of maximum volume and peak pressure (Pm). It 
is also the time lag between the peak and pause pressures. B is the amplitude of the net 
pressure waveform PN applied by the ventilator. This PN oscillates about Pel0 with amplitude 
of B. The difference between peak pressure Pm and pause pressure P0 is Δp. This figure is 
adopted from our work in Ref [3]. 
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The volume response to PN (the solution to Equation (32)) is given by: 
 
2 2
[sin( ) cos( )]
( )
1
a
t
ka a
a
BC t k t
V t He
k
ω ω ω
ω
⎛ ⎞
−⎜ ⎟⎜ ⎟⎝ ⎠−
= +
+
 (33) 
wherein: 
i. ka (= RaCa) is the averaged time constant, 
ii. the integration constant H is determined from the initial conditions, 
iii. the model parameters are Ca and ka (i.e., Ca and Ra), and 
iv. ωis the frequency of the oscillating pressure profile applied by the ventilator 
An essential condition is that the flow rate is zero at the beginning of inspiration and end of 
expiration. Hence, the flow rate dV/dt = 0 at t = 0. Applying this initial condition to our 
differential Equation (33), the constant H is obtained as: 
 
2 21
a a
a
BC k
H
k
ω
ω
=
+
 (34) 
Then, from Equations (33) and (34), we obtain: 
 
2 2 2 2
[sin( ) cos( )]
( )
1 1
a
t
ka a a a
a a
BC t k t BC k
V t e
k k
ω ω ω ω
ω ω
⎛ ⎞
−⎜ ⎟⎜ ⎟⎝ ⎠−
= +
+ +
 (35) 
 
For t = tv, V(t) is maximum and equal to the tidal volume (TV). Now in a normal person, ka is 
of the order of 0.1 and 0.5 in ventilated patients with respiratory disorders, which is relevant 
to our study of COPD patients. At t = tv at which the lung volume is maximum, we note 
from Figure 4 that tv is of the order of 2 s. Hence tv/ka is of the order 20-4, so that 
/ at ke−  is of 
the order of e -20 to e -4, which is very small and hence negligible. Hence, in Equation (35), we 
can neglect the exponential term so that, 
 
2 2
[sin( ) cos( )]
( )
1
a a
a
BC t k t
V t
k
ω ω ω
ω
−
=
+
 (36) 
Figure 4 illustrates a typical data of V, V$ and PN. For evaluating the parameter ka, we will 
determine the time at which V(t) is maximum and equal to the tidal volume (TV), Hence, 
putting  dV/dt = 0 in Equation (36), we obtain: 
 cos( ) sin( ) a
t
k
at k t eω ω ω
⎛ ⎞
−⎜ ⎟⎜ ⎟⎝ ⎠+ = , for t = tv (37) 
Hence from Equation (37), we obtain the following expression for ka: 
 tan( ) 1 / at kω ω= − , for t = tv (38-a) 
or,  
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 (1 / )tan( )a vk tω ω= −  (38-b) 
Since both ω and tv are known, we can evaluate ka from Equation (38-b). 
Now from Equation (38-b), we can put down: 
 
2 2
[sin( ) cos( )]
TV
1
a v a v
a
BC t k t
k
ω ω ω
ω
−
=
+
 (39) 
Since ω, tv and ka are known, we can now determine Ca in terms of TV and applied pressure 
amplitude B. 
Then knowing ka and Ca, we can determine 
 /a a aR k C=  (40) 
For our COPD patients, the ranges of the computed values of these parameters are:  
 ( ) ( ) 112 2 9 – 43  cmH 0 sL ;    0.020 – 0.080 L cmH 0a aR C −−= =  (41) 
Now that we have determined the expressions for the parameters Ra and Ca, the next step is 
to develop an integrated index lung ventilatory incorporating these parameters. 
5.4 Formulating a Lung Ventilatory Index (LVI) incorporating Ra and Ca 
We believe that the correlations between average airflow-resistance (Ra), average lung-
compliance (Ca), tidal volume (TV), respiratory rate (RF), and maximum inspiratory 
pressure or peak pressure (Pm) can be used as a possible indicator for determining lung-
status in a mechanically ventilated COPD patient with acute respiratory failure. We hence 
propose that a composite index (LVI), incorporating these isolated parameters, can have a 
higher predictive power for assessing lung status and determining when a patient on a 
mechanical ventilator. 
For this purpose, we note that COPD patients have higher Ra, lower Ca, lower TV, higher Pm 
and higher respiratory rate (or breathing frequency) RF. If we want the non-dimensional 
lung-ventilatory index (LVI) to have a high value for a COPD patient, further increasing LVI 
for deteriorating lung-status and decreasing LVI for improving lung-status in a 
mechanically ventilated COPD patient in acute respiratory failure, then the non-dimensional 
lung-ventilatory index (LVI) can be expressed, as given by Equation (30): 
 
2
2
2 2
(TV) ( )
(60)
( )
a
a m
R RF
LVI
C P
⎡ ⎤
= ×⎢ ⎥⎢ ⎥⎣ ⎦
 (42) 
where RF is the respiratory-rate frequency. 
Let us obtain the order-of-magnitude values of this LVI2 index for a mechanically ventilated 
COPD patient in acute respiratory failure (by using representative computed values of the 
parameters Ra, Ca, RF, TV, and Pm), in order to verify that the formula for LVI2 (given by 
Equation (42)) can enable distinct separation of COPD patients in acute respiratory failure 
from patients ready to be weaned off the respirator. For an intubated COPD patient, we 
have 
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1 2 1
22
2 1 2
2 2
[15(cmH O)sL ][0.5 L] [0.33 s ]
(Intubated COPD) (60)
[0.035 L(cmH O) ][20 cmH O]
LVI
− −
−
= × = 318 (43) 
wherein Ra = 15 (cmH2O)sL-1, Ca = 0.035 L(cmH2O)-1, RF = 0.33 s-1, TV = 0.5 L and 
Pm = 20 cmH2O. 
Now, let us obtain the order-of-magnitude of LVI (by using representative computed values 
of Ra, Ca, RF, TV, and Pm) for a COPD patient with improving lung-status just before 
successful discontinuation. For a successfully weaned COPD patient (examined in an 
outpatient clinic), we have 
 
1 2 1
22
2 1 2
2 2
[5(cmH O)sL ][0.35 L] [0.33 s ]
(Outpatient COPD) (60)
[0.10 L(cmH O) ][12 cmH O]
LVI
− −
−
= × = 50.5 (44) 
wherein Ra = 5 (cmH2O)sL-1, Ca = 0.10 L(cmH2O)-1, RF = 0.33 s-1, TV = 0.35 L and 
Pm = 12 cmH2O. 
Hence for LVI2 to reflect lung status improvement in a mechanically ventilated COPD 
patient in acute respiratory failure, there should be a pronounced decrease in the value of 
LVI2. This shows that the LVI given by Equation (42) can enable effective decision making to 
wean off a COPD patient from mechanical ventilator. 
Appendix:  
Solution procedure to obtain the best values of R, C, Pk and P0 provided in Equation (29). 
For the four unknowns R, C, Pk and P0, where  
 R: 2.1, 2.2, 2.3 (cmH2O)sL-1;  
 C: 0.20, 0.21, 0.22 L(cmH2O)-1 ;  
 Pk: 0.4, 0.5, 0.6 (cmH2O); 
 P0: 2.4, 2.5, 2.6 (cmH2O);  
we want to find the best values of R, C, Pk and P0 such that they satisfy the following 
equations: 
 0
0.3
(0.48)R P
C
+ =  (24) 
 
0.48
3.73 kP
C
=  (25) 
 0
0.48
0.33 kR P P
C
+ = +  (26) 
 
0.33
0.622 0R
C
− + =  (27) 
 0
0.55
P
C
=  (28) 
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Solution: 
We can rewrite Equations (26) to (30) so that the terms are collected at the LHS, i.e., 
 0
0.3
(0.48) 0R P
C
+ − =  (A-1) 
 
0.48
3.73 0kP
C
− =  (A-2) 
 0
0.48
0.33 0kR P P
C
+ − − =  (A-3) 
 
0.33
0.622 0R
C
− + =  (A-4) 
 0
0.55
0P
C
− =  (A-5) 
Since we are trying to find the best values of R, C, Pk and P0, the RHS of Equations (A-1) to 
(A-5) can be replaced by an error term so that 
 0 1
0.3
(0.48)R P e
C
+ − =  (A-6) 
 2
0.48
3.73 kP e
C
− =  (A-7) 
 0 3
0.48
0.33 kR P P e
C
+ − − =  (A-8) 
 4
0.33
0.622R e
C
− + =  (A-9) 
 0 5
0.55
P e
C
− =  (A-10) 
In general, we can represent the overall error incurred at any values of R, C, Pk and P0 by an 
objective function F so that 
 
5
0
1
( , , , )k i
i
F R C P P e
=
= ∑  (A-11) 
We can then find the best values of R, C, Pk and P0 but solving Equation (A-11) as  
an optimization problem with the aim to minimize F, subjected to the bounded 
constraints: 
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 2.1 ≤ R ≤ 2.3  
 0.20 ≤ C ≤ 0.22  
 2.4 ≤ P0 ≤ 2.6  
 0.4 ≤ Pk ≤ 0.6  
The optimal solution is obtained at F = 0.239539, and the associated best values of R, C, Pk 
and P0 are 
 R = 2.29425 cmH2O)sL-1 
 C = 0.219758 L(cmH2O)-1 
 Pk = 0.57926 (cmH2O) 
 P0 = 2.46702 (cmH2O)
              
(A-12) 
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